Skip to main content

Table 3 Circulating microRNAs in human leukemia

From: Clinical significance of microRNAs in chronic and acute human leukemia

Circulating miRNA

Expression in patients

Association with

blood cell count

Predict

prognosis

Predict Disease

progression

Predict Drug

response

miR-29

up in CLL exosome

Yes

Yes

–

–

miR-150

up in CLL exosome, low in

AML plasma

Yes

Yes

–

Yes

miR-155

up in CLL exosome, up in

AML plasma

Yes

Yes

Yes

Yes

miR-181b-5p

up in AML plasma

–

Yes

–

Yes

miR-210

up in AML serum

–

Yes

–

Yes

miR-375

up in AML serum

–

Yes

–

–

miR-511

up in B-ALL plasma

–

–

–

–

miR-222

up in B-ALL plasma

–

–

–

–

miR-34a

up in B-ALL plasma

–

–

–

–

miR-199a-3p

low in B-ALL plasma

–

–

–

–

miR-223

low in B-ALL plasma

–

–

–

–

miR-221

low in B-ALL plasma

–

–

–

–

miR-26a

low in B-ALL plasma

–

–

–

–

let-7d

low in AML plasma

–

–

–

–

miR-339

low in AML plasma

–

–

–

–

miR-342

low in AML plasma

–

Yes

–

–

let-7b

up in AML plasma

–

–

–

–

miR-523

up in AML plasma

–

–

–

–

miR-328

low in AML plasma

Yes

Yes

–

–

  1. The table reports the circulated microRNAs that have been identified in human leukemia (CLL, CML, ALL, AML and ATL) and their role in prognosis, disease progression, drug response or association with blood cell count